AstraZeneca CEO Pascal Soriot joins 'Squawk on the Street' to discuss the company's quarterly earnings results, its goal to double sales by 2030, and its Farxiga drug..
AstraZeneca CEO Pascal Soriot joins 'Squawk on the Street' to discuss the company's quarterly earnings results, its goal to double sales by 2030, and its Farxiga drug.
AstraZeneca CEO Pascal Soriot joins 'Squawk on the Street' to discuss the company's quarterly earnings results, its goal to double sales by 2030, and its Farxiga drug..